100982552YH

Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-

2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

BIOCHEMISTRY
Glucose, Fasting
Fluoride Plasma,Glucose Oxidase- 88 70 - 99
Peroxidase (GOD-POD)
MC-6367

Glycated Hemoglobin (HbA1C)

Whole Blood

Glycated Hemoglobin (HbA1C) Normal: < 5.7

High-Performance Liquid Chromatography 5.2 % Pre-Diabetes: 5.7-6.4
(HPLC) Diabetes: => 6.5
MC-6367

Mean Blood Glucose 103 mg/dL < 117

Calculated

HbA1C is used to monitor fluctuations in blood glucose concentration in the past 8 to 12 week's period.
The reference interval defined as per American Diabetes Association guidelines 2016:
Less than 5.7%: Non Diabetic
5.7 to 6.4%: at increased risk of developing diabetes in the future
More than 6.5%: Diabetic
Therapeutic glycemic target
Adults: less than 7%
Children with Type 1 diabetes: less than 7%
Pregnant diabetic patients: less than 6.5%
Note: Targets may be individualized based on: Age/life expectancy, Comorbid conditions, Diabetes duration, Hypoglycemia status,
Individual patient considerations
Reference: American Diabetes Association. Standards of medical care in diabetes - 2021.
Mean Blood Glucose is average Blood glucose which directly correlates with A1C, reported in the same units as blood sugar levels (mg/dl).
Thus it reflects the average glucose concentration in the past 8 to 12 weeks period. This should not be compared with Fasting or Post
prandial or random blood sugar which measures glucose concentration at that point of time of testing.

Lipid Profile
Serum
Cholesterol, Total
Cholesterol Esterase/Cholesterol 159 mg/dL < 200
Oxidase/Peroxidase
MC-6367
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Triglycerides 109 mg/dL < 150
MC-6367
Cholesterol Oxidase
High-Density Lipoprotein (HDL)
Cholesterol 32 mg/dL > 50
MC-6367
Cholesterol Esterase/Cholesterol
Oxidase/Peroxidase
Non-High Density Lipoprotein
(Non-HDL) Cholesterol 127 mg/dL < 130
Calculated
Low-Density Lipoprotein (LDL)
Cholesterol 105 mg/dL < 100
Calculated
MC-6367

Very Low-Density Lipoprotein

(VLDL) Cholesterol 22 mg/dL < 30
Calculated
Cholesterol/High Density
Lipoprotein (HDL) Ratio 5 3.3 - 4.4
Calculated
Low-Density Lipoprotein/High-
Density Lipoprotein (LDL/HDL) 3.3 0.5 - 3
Ratio
Calculated
High-Density Lipoprotein/Low-
Density Lipoprotein (HDL/LDL) 0.3 > 0.4
Ratio
Calculated

Remarks Total Cholesterol (mg/dL) Triglycerides (mg/dL) LDL Cholesterol (mg/dL)

Optimal <200 <150 <100
Above Optimal - - 100-129
Borderline 200-239 150-199 130-159
High ≥ 240 200-499 160-189
Very High - ≥ 500 ≥ 190
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Lipid profile is a group test consisting of various lipids. Lipid profiles are generally collected with overnight fasting. However, recent
guidelines have recommended non fasting samples for lipid profile for assessment of cardiovascular risk. The details for the study can be
checked at https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2733560
In certain instances measurements in the same patient can show physiological and analytical variations. In such cases three serial samples
at an interval of 1 week each are recommended for Total cholesterol, TG, HDL and LDL.
Cholesterol levels are increased in primary hypercholesterolemia; secondary hyperlipoproteinemia, including nephrotic syndrome; primary
biliary cirrhosis; hypothyroidism; and in some cases, diabetes mellitus. Low cholesterol levels may be found in malnutrition, malabsorption,
advanced malignancy, and hyperthyroidism.
Triglyceride levels are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases
involving lipid metabolism, or various endocrine disorders.
High Density Lipoprotein (HDL) cholesterol levels is used to evaluate the risk of developing coronary heart disease (CHD). The risk of CHD
increases with lower HDL cholesterol concentrations.
LDL (low-density lipoprotein) cholesterol level, sometimes called "bad" cholesterol, makes up most of our body’s cholesterol. High levels
of LDL cholesterol raise your risk for heart disease and stroke.
Very-low-density lipoprotein (VLDL) cholesterol is produced in the liver and released into the bloodstream to supply body tissues with
triglycerides. High levels of VLDL cholesterol have been associated with the development of plaque deposits on artery walls, which narrow
the passage and restrict blood flow.

Liver Function Test (LFT)

Serum
Bilirubin, Total 1.17 mg/dL 0.2 - 1.3
MC-6367
Diazo Method
Bilirubin, Direct 0.24 mg/dL 0 - 0.3
MC-6367
Calculated
Bilirubin, Indirect 0.93 mg/dL 0.1 - 1.1
Reflectance Spectrophotometry
Aspartate Aminotransferase (AST)
Multipoint-Rate/UV with Pyridoxal-5- 20 U/L 17 - 49
Phosphate (P-5-P)
MC-6367

Alanine Transaminase (ALT) 20 U/L <50

MC-6367
LDH, UV Kinetic
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Aspartate
Aminotransferase/Alanine 1.0 0.7 - 1.4
Transaminase (AST/ALT) Ratio
Calculated
Alkaline Phosphatase (ALP)
Multipoint-Rate/UV with Pyridoxal-5- 70 U/L 38 - 126
Phosphate (P-5-P)
MC-6367

Gamma-Glutamyl Transpeptidase
(GGT) 31 U/L 15 - 73
SZAZ Carboxylated Substrate
MC-6367

Protein 7.3 g/dL 6 - 8.3

MC-6367
Biuret
Albumin 4.8 g/dL 3.5 - 5
MC-6367
Bromo-Cresol Green
Globulin 2.5 g/dL 2.3 - 3.5
Calculated
Albumin/Globulin (A/G) Ratio 1.9 0.8 - 2
Calculated

In certain individuals, total bilirubin up to 2.0 mg/dl is considered normal. High bilirubin values can be due to jaundice.
Total bilirubin is invariably increased in jaundice. Causes of jaundice are prehepatic, resulting from various hemolytic diseases; hepatic,
resulting from hepatocellular injury or obstruction; and posthepatic, resulting from obstruction of the hepatic or common bile ducts.
Increased direct bilirubin levels can occur in hepatobiliary disorders, including intrahepatic and extrahepatic biliary tree obstruction, liver
cell damage, Dubin-Johnson syndrome, and Rotor syndrome.
High indirect bilirubin levels can occur in hemolytic disorders, Gilbert’s syndrome, Crigler-Najjar syndrome, neonatal jaundice, and
ineffective erythropoiesis.
High Aspartate Aminotransferase values can occur in Myocardial infarction, pulmonary emboli, skeletal muscle trauma, alcoholic cirrhosis,
viral hepatitis, or drug-induced hepatitis.
Elevated Alanine Aminotransferase levels are seen in liver cell necrosis, hepatitis, hepatic cirrhosis, liver tumours, obstructive jaundice,
Reye’s syndrome, extensive trauma to skeletal muscle, myositis, myocarditis, or myocardial infarction.
High alkaline phosphatase levels can be be due to primary and secondary hyperparathyroidism, Paget’s disease of bone, carcinoma
metastatic to the bone, osteogenic sarcoma, Hodgkin’s disease, Hepatobiliary diseases involving cholestasis, inflammation, or cirrhosis.
ALP levels can also be elevated in fever and increased bone metabolism(e.g., in adolescents and during the healing of a fracture), in renal
infarction and failure and in pregnancy complications.
Low ALP levels may occasionally be seen in hypothyroidism.
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Gamma-glutamyl transferase (GGT) is a sensitive indicator of hepatobiliary disease. It is useful in the diagnosis of obstructive jaundice
and chronic alcoholic liver disease, in the follow-up of chronic alcoholics undergoing treatment, and in the detection of hepatotoxicity. GGT
is more responsive to biliary obstruction than AST, ALT, or ALP.
Total protein levels can be used to evaluate nutritional status.
High protein concentrations can be due to dehydration, Waldenström’s macroglobulinemia, multiple myeloma, hyperglobulinemia,
granulomatous, and some tropical diseases.
Low protein concentrations can be due to pregnancy, excessive intravenous fluid administration, cirrhosis or other liver diseases, chronic
alcoholism, heart failure, nephrotic syndrome, glomerulonephritis, neoplasia, protein-losing enteropathies, malabsorption, and severe
malnutrition.
Increased albumin levels may indicate dehydration or hyperinfusion with albumin.
Decreased albumin levels are found in rapid or over-hydration, severe malnutrition and malabsorption, severe diffuse liver necrosis,
chronic active hepatitis, and neoplasia.
Albumin is commonly reduced in chronic alcoholism, pregnancy, renal protein loss, thyroid dysfunction, peptic ulcer disease, and chronic
inflammatory diseases.
Globulin includes carrier proteins, enzymes, complement, and immunoglobulins. Most of these are synthesised in the liver, although
immunoglobulins are synthesised by plasma cells.
Increased globulin level usually results from an increase in immunoglobulins.
Malnutrition and congenital immune deficiency can decrease globulin levels due to decreased synthesis. Nephrotic syndrome can cause
decreased globulin levels due to protein loss through the kidney.
AST/ALT Ratio > 2:1 (AST is two times higher than ALT) is indicative of alcoholic liver disease.
AST/ALT Ratio < 1:1 (ALT is higher than AST) indicates non-alcoholic fatty liver disease.

Kidney Function Test (KFT) Mini

Serum
Urea 22 mg/dL 19 - 43
MC-6367
Urease
Creatinine 0.9 mg/dL 0.66 - 1.25
MC-6367
Twopoint-Rate-Creatinine Aminohydrolase
Blood Urea Nitrogen (BUN) 10.3 mg/dL 6 - 20
Calculated
Blood Urea Nitrogen
(BUN)/Creatinine Ratio 11.44 Ratio 10 - 20
Calculated
Uric Acid 7.3 mg/dL 3.5 - 8.5
MC-6367
Uricase
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Calcium 9.8 mg/dL 8.4 - 10.2
MC-6367
Arsenazo Method
Normal: => 90
Estimated Glomerular Filtration Mild decrease: 60-89
Rate (eGFR) 119 ml/min/1.73m² Mild moderate decrease: 45-59
Twopoint-Rate-Creatinine
Aminohydrolase/Calculation Severe decrease: 15-29
End stage kidney disease: < 15
High urea and BUN levels are suggestive of poor kidney function due to acute or chronic kidney diseases, decreased blood flow to the
kidneys as in congestive heart failure, shock, stress, recent heart attack or severe burns, bleeding from the gastrointestinal tract,
conditions that obstruct urine flow or dehydration.
Low urea and BUN levels are uncommon and are not usually a cause for concern. They can be seen in severe liver disease or malnutrition
but are not used to diagnose or monitor these conditions. Low urea levels are also seen in normal pregnancy.
Creatinine is elevated in kidney disease, damage, infection, urinary tract obstruction, reduced blood flow to the kidneys in case of shock,
congestive heart failure, complications of diabetes.
High levels of uric acid are seen in kidney disease, pre-eclampsia, purine-rich food, alcoholism, and side effects of cancer treatment.
Low calcium levels may be due to hypoparathyroidism, kidney failure, pancreatitis, malnutrition, or a disorder in calcium absorption.
High calcium levels may be due to hyperparathyroidism, hyperthyroidism, sarcoidosis, drugs like diuretics, and excessive calcium
supplementation.
High phosphorus levels can be due to dehydration, hypoparathyroidism, hypervitaminosis D, metastases to bone, sarcoidosis, pulmonary
embolism, renal failure, or diabetes mellitus with ketosis.
Low phosphorus levels can be caused by hyperparathyroidism, high calcium levels, sepsis, vitamin D deficiency, renal tubular disorders,
chronic hemodialysis, vomiting, or occasionally decreased dietary phosphate intake.
Chronic Kidney Disease often has no symptoms until the later stages. So, reliable estimates of GFR are important for identifying the disease
as early as possible.
Factors that can affect eGFR include pregnancy, being over the age of 70, unusual muscle mass, cirrhosis, nephrotic syndrome, a past
solid organ transplant, and some medications.
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:26 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Approved By

Dr. Ankita Singh

MBBS, MD (Pathology)
Pathologist
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 09:14 AM Partner : Getvisit TPA

Test Results Units Biological Reference

HAEMATOLOGY
Complete Blood Count (CBC) with ESR
Whole Blood
Red Blood Cells (RBC) Count 5.30 mill/mm³ 4.5 - 5.5
MC-6367
DC Impedance Method
Hemoglobin (Hb) 14.9 g/dL 13 - 17
MC-6367
Cyanide-free SLS method
Hematocrit (HCT) | Packed Cell
Volume (PCV) 44.3 % 40 - 50
Calculated
MC-6367

Mean Corpuscular Volume (MCV) 83.6 fL 83 - 101

MC-6367
Calculated
Mean Corpuscular Hemoglobin
(MCH) 28.1 pg 27 - 32
Calculated
MC-6367

Mean Corpuscular Hemoglobin

Concentration (MCHC) 33.6 g/dL 31.5 - 34.5
Calculated
MC-6367

Red Cell Distribution Width (RDW)

CV 13.0 % 11.6 - 14
Calculated

Mentzer Index 16.0 Thal trait: <14, Iron deficiency anaemia

Calculated : >=14
Sehgal Index 1319.0 Beta Thalassemia trait: < 972
Calculated Iron deficiency anaemia: => 972
Total White Blood Cell Count (TC) 4710 cells/mm³ 4000 - 10000
MC-6367
Flow Cytometry

Differential Count
Neutrophils 52.5 % 40 - 80
Flow Cytometry
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 09:14 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Lymphocytes 40.3 % 20 - 40
Flow Cytometry
Monocytes 4.9 % 2 - 10
Flow Cytometry
Eosinophils 1.6 % 1-6
Flow Cytometry
Basophils 0.7 % 0-2
Flow Cytometry
Absolute Neutrophil Count (ANC) 2473 /mm³ 2000 - 7000
Calculated
Absolute Lymphocyte Count (ALC) 1898 /mm³ 1000 - 3000
Calculated
Absolute Monocyte Count (AMC) 231 /mm³ 200 - 1000
Calculated
Absolute Eosinophil Count (AEC) 75 /mm³ 20 - 500
Calculated
Absolute Basophil Count (ABC) 33 /mm³ 0 - 100
Calculated
Neutrophil Lymphocyte Ratio
(NLR) 1.3 1-3
Calculated
Platelet Count 285 10^3/µL 150 - 450
DC Impedance Method
Platelet Hematocrit 0.274 % 0.2 - 0.5
Calculated
Mean Platelet Volume (MPV) 9.6 fL 7 - 13
MC-6367
Calculated
Erythrocyte Sedimentation Rate
(ESR) 2 mm/h 0 - 10
Quantitative Capillary Photometry
MC-6367

Reference Ranges are in accordance with Dacie & Lewis Practical Hematology International Edition (12th)
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 09:14 AM Partner : Getvisit TPA

Test Results Units Biological Reference

As per International Council for Standardization in Hematology's recommendations Differential Leucocyte counts are additionally
reported in Absolute numbers in each cell per unit volume of blood.

Approved By

Dr. Ankita Singh

MBBS, MD (Pathology)
Pathologist
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:09 AM Partner : Getvisit TPA

Test Results Units Biological Reference

IMMUNOLOGY
Thyroid Stimulating Hormone
(TSH) 2.523 µIU/mL 0.4 - 4.049
Serum,Chemiluminescent Immunoassay
MC-6367
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:09 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Clinical Significance:
Thyroid Stimulating Hormone (TSH), also called Thyrotropin is a hormone secreted into the blood by the Pituitary gland (a gland present in
the brain). It signals the thyroid gland to make and release the thyroid hormones (T3 & T4) into the blood.
High TSH level indicates that the thyroid gland is not making enough thyroid hormone (primary hypothyroidism). Low TSH level usually
indicates that the thyroid is producing too much thyroid hormone (hyperthyroidism).

Factors influencing TSH levels

TSH level shows a significant decline after meal intake in comparison to fasting values. If the patient is taking any thyroid medication
different times each day, they may sometimes be taking the thyroid hormone on an empty stomach, and sometimes with or after having
food. This may have clinical implications in the diagnosis and management of hypothyroidism, especially Subclinical hypothyroidism.
Circadian Rhythm: TSH levels follow a circadian variation, reaching peak levels between Morning 2 - 4 am and at a minimum between
Evening 6-10 pm. The above graph considers a sleep window of 11:00 PM to 7:30 AM. The variation is of the order of 50%. There are
studies which quote variations up to 70 % depending on when the sample is drawn during which time of the day. Hence time of sample
collection during a day can significantly influence on the measured serum TSH concentrations.
Other Factors: It is important to recognize that TSH is a labile hormone and is subject to non-thyroidal pituitary influences
(glucocorticoids, somatostatin, dopamine etc.), stress, activity, that can disrupt the TSH/FT4 relationship. Genetics, Poisonous
substances and radiation exposure, Inflammation of the thyroid gland, Deficiency or excess of iodine in the diet, Pregnancy, Certain
medications – antidepressants, cholesterol lowering drugs, chemotherapy drugs, steroids, Thyroid cancer.
In pregnant females the reference range of TSH differs. Please refer the table below for the same:-
PREGNANCY TSH REFERENCE RANGE (µIU/mL)
1st Trimester 0.100-2.500
2nd Trimester 0.200-3.00
3rd Trimester 0.300-3.00
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:09 AM Partner : Getvisit TPA

Test Results Units Biological Reference

References:
Indian Journal of Endocrinology and Metabolism 18(5):p 705-707, Sep-Oct 2014.
http://www.pnei-it.com/1/upload/thyrotropin_secretion_patterns_in_health_and_disease.pdf

Deficient: < 20
Vitamin D, 25-Hydroxy 23.2 ng/mL Insufficient: 20-30
MC-6367 Serum,Chemiluminescent Immunoassay Sufficient: 30-100
Toxicity: > 100
Clinical Significance:
For the diagnosis of vitamin D deficiency, it is recommended that there be a clinical correlation with serum 25(OH)vitamin D, calcium,
parathyroid hormone, and alkaline phosphatase.
While monitoring oral vitamin D therapy, serum 25(OH)vitamin D should be tested after 3 months of treatment. However, the required
dosage of vitamin D supplements and time to achieve target vitamin D levels show seasonal and individual variability depending on age,
body fat, sun exposure, physical activity, genetic factors (especially variable vitamin D receptor responses), associated liver or renal
disease, malabsorption syndromes, and calcium or magnesium deficiency influencing the metabolism of vitamin D.

Approved By

Dr. Ankita Singh

MBBS, MD (Pathology)
Pathologist
 100982552YH
Mr NELLUTLA SRIKANTH Collected : 27/04/2025 07:02 AM Report Ref. ID : HYD2202795-
2552890
28 Year(s)/Male Received : 27/04/2025 08:31 AM Patient ID : OHPATCCR1342834
Ref. by : - Reported : 27/04/2025 10:09 AM Partner : Getvisit TPA

Test Results Units Biological Reference

Reviewed By

Dr. Ankita Singh

MBBS, MD (Pathology)
Pathologist

CONDITIONS OF LABORATORY TESTING & REPORTING

Tests marked with NABL symbol are accredited by NABL vide certificate no MC-6367
It is presumed that the test sample belongs to the patient named or identified in the test requisition form. Test results released pertain to
the specimen submitted.
Laboratory investigations are only a tool to facilitate arriving at a diagnosis and should be clinically correlated by the Referring Physician.
All tests are performed and reported as per the turnaround time stated in the Orange Health Labs Directory of Services (DOS).
Orange Health Labs confirms that all tests have been performed or assayed with the highest quality standards, clinical safety & technical
integrity.
All test results are dependent on the quality of the sample received by the Laboratory and the assay technology.
Report delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted.
A requested test might not be performed if:
The specimen received is insufficient or inappropriate, or the specimen quality is unsatisfactory
Incorrect specimen type
Request for testing is withdrawn by the ordering doctor or patient
There is a discrepancy between the label on the specimen container and the name on the test requisition form
Test results may show interlaboratory variations.
Test results are not valid for medico-legal purposes.
This is a computer-generated medical diagnostic report that has been validated by an Authorized Medical Practitioner/Doctor. The report
does not need a physical signature.
This report does not contain results for following test(s) because sample(s) were not received for them as
patient denied these tests to be conducted.

- Urine Routine Analysis